Callan Family Office’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.4M Buy
75,930
+16,390
+28% +$1.29M 0.12% 179
2025
Q4
$4.88M Buy
59,540
+5,510
+10% +$429K 0.1% 191
2025
Q3
$4.06M Sell
54,030
-2,177
-4% -$162K 0.13% 169
2025
Q2
$4.16M Buy
56,207
+39,152
+230% +$2.73M 0.13% 173
2025
Q1
$1.38M Sell
17,055
-138
-0.8% -$11.9K 0.1% 169
2024
Q4
$1.34M Buy
+17,193
New +$1.46M 0.09% 197
2023
Q2
Sell
-4,899
Closed -$402K 130
2023
Q1
$402K Buy
+4,899
New +$350K 0.1% 108

Other funds holding GEHC

Callan Family Office's GEHC Position: Q1 2026 in Review

Callan Family Office increased its GE HealthCare (GEHC) stake by 28% in Q1 2026, buying an estimated $1.29M and bringing the position to 75,930 shares worth $5.4M. The position accounts for 0.12% of the portfolio, ranked #179.

Callan Family Office first reported a position in GEHC in Q1 2023 and has held it in 7 quarters since. 1,263 funds tracked by Wall St. Rank hold GEHC as of Q1 2026.

  • Callan Family Office held 75,930 shares of GE HealthCare worth $5.4M as of Q1 2026.
  • Callan Family Office bought 16,390 GE HealthCare shares in Q1 2026, an estimated $1.29M.
  • GE HealthCare made up 0.12% of Callan Family Office's portfolio in Q1 2026, its #179 holding.
  • Callan Family Office first reported a position in GE HealthCare in Q1 2023 and has held it in 7 quarters since.
  • 1,263 funds tracked by Wall St. Rank held GE HealthCare as of Q1 2026.

Based on Callan Family Office's 13F filing for Q1 2026, filed 13 May 2026.